Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCL3 antisense RNA 1 (CCL3-AS1)
- Target
- CCL3-AS1
- Molecular classification
- Other, long non-coding RNA, antisense RNA
01
Overview
CCL3 antisense RNA 1 (CCL3-AS1) is a long non-coding antisense RNA gene located on chromosome 17q12, adjacent to the CCL3 chemokine gene. It features several splice variants and its patterns of expression and function remain to be clarified in the scientific literature. Unlike the protein-coding CCL3, which plays a role in inflammation and immune recruitment, CCL3-AS1 does not encode a protein and is not currently recognized as a therapeutic target. No drugs or biomarkers are associated with its targeting, and its biological role remains under investigation. If you require information on the protein-coding CCL3, often confused with the antisense RNA, it is a chemokine with verified involvement in immune response and inflammation.
- Other names
- CCL3-AS1
02
Mechanism of action
No drugs currently target CCL3-AS1, therefore no defined mechanism of action. For generic antisense RNA targets, mechanisms could involve RNA interference or epigenetic regulation, but this is speculative for CCL3-AS1.
03
Biological functions
Patterns of expression and functions remain to be clarifiedPossible roles include gene expression regulation of neighboring genes (potentially CCL3)
04
Disease associations
Not specifically established
05
Safety considerations
None reportedSafety profile unknown (not currently targeted in therapeutic applications)
Beyond the preview
Go deeper on CCL3 antisense RNA 1 (CCL3-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CCL3 antisense RNA 1 (CCL3-AS1).